This study presents the three-dimensional (3D) measurement of the dose distribution delivered using the RapidArc TM technique and MAGAT polymer gel with cone-beam CT (CBCT) as the dose reading tool. 3D verification of clinical prostate quality assurance (QA) plan was performed and analyzed. The MAGAT normoxic polymer gel consisted of methacrylic acid (monomer purity > 98%), gelatin from procine skin (type A, Sigma Aldrich), and tetrakis (hydroxymethyl) phosphonium choloride (THPC) (80% solution in water). A linear accelerator (Varian) with CBCT was used for radiation delivered and CBCT as dose reader. Corresponding QA plans of RapidArc TM plans of two prostate cancer cases were selected for dose comparison measurements. 3D gamma comparisons, dose profiles, and 3D volumes were used for evaluation. The dose response curve of the MAGAT polymer gel was acquired as x = 9.79y-13154 with R 2 = 0.9794, where y is the CT number and x is the radiation dose in cGy. The 3D gamma analysis was performed using comparisons of volumes in 90% and 80% isodose between treatment planning system calculation and gel phantom measurement for the prostate cases. In the 90% isodose covered volume, 96.3% of points were within 5%/5 mm (dose difference/distance to agreement) and 91.2% of points were within 3%/3 mm. In the 80% isodose volume, the pass rates were 98.7% and 96.1%, respectively. Excellent 3D dose measurement quality for the RapidArc TM delivery technique was achieved with the MAGAT polymer gel and CBCT scan.
Introduction
The RapidArc TM technique takes advantage of intensity modulated radiotherapy (IMRT) and image guidance. The image guidance system provides accurate localization before beam delivery. The beam delivery can be a 360 arc with dynamic multi-leaf motion to control the irradiation size and dose rate, and can thus deliver the same quality of dose distribution as that of conventional IMRT or even better with fewer monitor units (MU). The first treatment of a cancer patient with this technique was carried out very recently and thus few scientific articles regarding the use of RapidArc TM have been published. The RapidArc TM technique is an accurate, fast, and effective dose delivery method in radiotherapy [1] . The advanced inhomogeneous three-dimensional (3D) using conventional means, such as single dose point measurements or two-dimensional (2D) detector arrays. In dose measurement, the most commonly used detectors include thermoluminescent dosimeters (TLD), ion chambers, and films. Ion chambers measure the ionized charge or current in a material to get the absorbed radiation dose or dose rate. TLD is good for recording personal accumulated dose. The major drawbacks are a complicated dose reading process and only point dose measurement. Film is often used to measure dose distribution. Advantages include high spatial resolution and 2D dose measurement. Although the above dose measurement methods are commonly applied in clinical dose measurement and the accuracy of the measurements is reasonably good, they can only provide 1D or 2D dose data. Dosimeter materials are usually not equivalent to tissue and are thus not applied in 3D tissue absorbed dose measurement. The present study uses a gel dosimeter for 3D radiation measurement. A gel dosimeter can directly measure the 3D dose distribution in the entire irradiated volume since the gel integrates the absorbed dose and the response is independent of the incident radiation direction [2] . The dosimeter material is tissue equivalent [3] . In addition, a gel dosimeter is not energy-dependent, and has a high spatial resolution. Thus, it can provide a true 3D tissue dose distribution.
There are two categories of gel dosimeters, namely Fricke gel and polymer gel. Fricke gel was the first used to measure 3D dose distribution [4] . However, its dose sensitivity is low and the dose measurement range is small. Therefore, Fricke gel is not applied clinically in dose measurement. The principle of polymer gel is that polymerization occurs when a monomer is irradiated, forming a polymer in gel. Polymerization can thus be used to measure radiation dose changes [5] .
There are two kinds of polymer gel based on their preparation environment. One is BANG polymer gel, which is produced under anoxic conditions, and the other is normoxic polymer gel, which is prepared under normal conditions. The first normoxic polymer gel was MAGIC, whose dose sensitivity range is reasonably acceptable and which can be made under normal temperature and pressure [6] . De Deene et al. simplified the components of MAGIC and made methacrylic acid gelatin gel and tetrakis (hydroxymethyl) phosphonium choloride (THPC) (MAGAT) normoxic polymer gel. The tissue equivalence and dose sensitivity of MAGAT normoxic polymer are better than those of MAGIC normoxic polymer [7] .
Many dose measurement studies using polymer gel have used magnetic resonance imaging (MRI), optical computed tomography (OCT), X-ray computed tomography (CT), and cone-beam computed tomography (CBCT) as dose reading tools [8, 9, 10] . Among them, MRI has been most often applied [11] . However, MRI is not as available as other tools in radiation oncology organizations. Therefore, MRI is not as convenient as CT or CBCT in most radiation oncology institutes. CBCT systems are usually part of a linear accelerator, which acquires volumetric images and conveniently enables treatment target alignment immediately prior to treatment delivery. The present study uses CBCT as the dose reading tool due to its convenience and feasibility. CBCT to read the dose in a polymer gel in real time or near real time after the dose is delivered by the accelerator.
The present study uses MAGAT polymer gel to measure the 3D dose distribution delivered using the RapidArc TM technique and uses CBCT as the dose reading tool. The measured dose distribution is then compared with that calculated using the treatment planning system (TPS). The differences between the measured and calculated dose distributions are analyzed using the 3D gamma method [12] .
Materials and methods

Preparation of MAGAT polymer gel
MAGAT polymer gel consisting of methacrylic acid (MAA) (monomer purity > 98%, Sigma Aldrich), gelatin from procine skin, type A (Sigma Aldrich), THPC (80% solution in water, Sigma Aldrich), and distilled water was prepared. In this solution, MAA is the monomer component, the gelatin is the base material, and THPC is the oxygen scavenger, which allows the gel to be prepared in normoxic conditions. The composition is listed in Table 1 . The MAGAT polymer gel preparation started with the mixing of the gelatin with distilled water at room temperature. The mixture was then heated to 50 C with stirring for 30 minutes. As the gelatin solution became clear, the temperature was decreased to 35 C and THPC and MAA solutions were added to the mixture under stirring. Finally, ten 50-ml vials and acrylic tanks (10  10  13 cm 3 ) were filled with the prepared MAGAT polymer gel. The gels were prepared under normal levels of oxygen and the solutions were stirred continuously throughout the entire mixing procedure.
Dose delivery and RapidArc TM treatment planning
In this study, a linear accelerator (Varian Medical Systems, Palo Alto, USA) was used to deliver a radiation dose to the MAGAT polymer gel using a 6-MV photon beam. For the dose response curves, the polymer gel vials were irradiated with opposed lateral beams of 90 and 270 to 0, 50,100, 150, 200, 250, 300, 350, and 400 cGy, respectively. From the radiation dose exposure and CT scans, the corresponding CT number to dose was calculated according to the dose response curve.
Two RapidArc TM plans of prostate cancer cases were selected in this study. The beam energy used in the plans was 6 MV. The treatment plan optimization dose was delivered during a single gantry arc of up to 360°. The corresponding quality assurance (QA) plans were generated for the polymer gel phantoms (10  10  13 cm 3 ) for the prostate cases. The average dose to a phantom was 3.1 Gy. The QA plans were delivered using 6 MV beams from the accelerator.
Cone-beam CT dose reading and image processing
After the delivery of doses, the polymer gel vials and phantoms were scanned using the on-board imager (OBI, Varian Medical Systems, Palo Alto, USA) cone-beam CT (CBCT) to read the 3D doses in near real time. The parameters used in CBCT scans were 80 kV, 50 mA, and a slice thickness of 1 mm. There were 512  512 pixels in each slice. To consider the extra dose from the CBCT scan, background subtraction was performed for every gel dose image. In this study, image processing was performed on the Microsoft Visual C++ platform. All the images were first processed with a mean filter to enhance the variation of signals in the images. The dose response curve was obtained by measuring the HU, the change in Hounsfield Units between the images of polymer gel vials which received various doses. The 3D dose distributions were calculated by applying the obtained dose response curve to every voxel in the 3D CBCT images of the polymer gel phantoms.
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Data analysis and comparison
The measured 3D dose distributions in the MAGAT polymer gel dosimeter were compared with the dose distributions of the QA plans calculated by TPS. The QA plan and the MAGAT polymer gel relative absorbed dose volumes were aligned by matching the inner surface of the glass containers at the isocenter plane. A 3D isodose comparison was generated from the 3D dose distribution comparison. In addition, the dose differences between the measured and TPS calculated dose distributions were analyzed using the 3D gamma analysis method.
3D gamma analysis was used to investigate differences between the gel measurement and the TPS calculation. Each measured point was evaluated to determine whether both the dose difference and distance to agreement (DTA) exceeded the selected tolerances. The DTA is the distance between a measured data point and the nearest point in the calculated dose distribution that exhibits the same dose.
Results
The experimental gel dosimetry 3D measurements carried out in this study were used for verification of the absorbed dose delivery using a volumetric modulated arc therapy (VMAT) technique (RapidArc™). The dose response is shown in Fig. 1 where y is the CT number and x is the radiation dose in cGy. The accuracies of the self-developed gel dosimeter including absolute and relative errors for 50 to 400 cGy measurements are listed in Table 2 . The maximum error of measurement was for the 50-cGy measurement. The errors decreased with increasing radiation. Fig. 3(a) is shown in Fig. 3(b) , where the red curve represents the dose profile from TPS and the blue one is that from the measurement. Below 90%, they almost match completely. Above 90%, the difference is larger, which indicates that the response of the polymer gel may not be stable at high dose. Figure 4 shows the 90% isodose covered volumes in 3D of (a) TPS and (b) gel phantom measurements. The shapes of the volumes are similar. Based on the figures, it can be concluded that the measured dose distribution agrees with TPS results reasonably well. The 3D gamma analysis was performed on the comparison of 90% and 80% isodose areas and the critical organs between TPS calculation and gel phantom measurement. The pass rates for 5%/5 mm and 3%/3 mm (dose difference/DTA) were calculated. The results are listed in Table 3 . In the 90% isodose covered volume, 96.3% of points were within 5%/5 mm and 91.2% of points were within 3%/3 mm. In the 80% isodose volume, the pass rates were 98.7% and 96.1%, respectively. Gamma evaluation for critical organ areas passed both 3%/3 mm and 5%/5 mm criteria. 
Discussion
This study verified the absorbed dose delivery produced by the volumetric arc therapy technique RapidArc™ using 3D MAGAT polymer gel with CBCT for radiation dose measurement and validation. The relative absorbed dose distributions of gel dosimeters were calculated and compared those obtained using TPS by matching the inner surface of the acrylic tanks in the isocenter planes.
Irradiated gel vials were used to obtain a linear curve from gel (HU) to radiation dose. With the dose response curve, the CBCT images of an irradiated gel phantom were directly translated to absorbed dose distributions. The R 2 value of the fitted linear equation for the dose response curve (Fig. 1 ) was 0.98, which is acceptable considering the good agreement between the converted dose distributions from the gel phantom images and the distributions calculated using TPS. In order to achieve real-time 3D radiation dose measurement, CBCT as the dose reading tool introduces several challenges. 80 kV, 50 mA CBCT was used as a dose reader, whose energy was considerably lower than that used in a previous study in which conventional CT (120 kV, 200 mA) was applied [13] . The increased number of scattered photons generated by interacting photons with low energy contribute more noise during imaging, leading to R 2 = 0.98 for the dose response curve (Fig. 1 ). The CBCT sensitivity, which is represented by the gray level range or △CT number range of 0-40 in response to a dose in the range of 0 to 400 cGy, is comparable to that obtained using conventional CT as a dose reader [13] .
The agreement between the measured distribution and the distribution calculated from TPS is emphasized in Fig. 2 , which shows overlay isodose-line intercomparisons for given slices. The 90% isodose line from TPS and that from gel measurement are very close to each other. A comparison of dose profiles is plotted in Fig. 3(b) showing the agreement in the low-dose and high-dose region. There are regions where two measurements in prostate QA cases show differences, with TPS results midway between the measurements. In general, no consistency or systematic trends can be discerned. The distributions appear very similar, with discrepancies within the noise limit. Any variation in the mechanics of the delivery would also contribute to differences in the measured distribution. The volume enclosed by the 90% isodose surface was calculated and projected in 3D view (Fig. 4) showing the coherent results of dose distributions obtained using TPS and gel measurement for the 90% isodose surface. Gamma index analysis was used to investigate differences between gel measurement and TPS. Qualitative comparison tools like isodose plots and overlays illustrate the encouraging performance of the gel/CBCT system for RapidArc™ dose verification. A quantitative estimate of the extent of agreement/ disagreement is, however, required for comprehensive comparative analysis.
In this study, comparative gamma index analysis was used to investigate differences between gel measurement and TPS, with acceptance criteria of 3%/3 mm and 5%/5 mm (dose difference/DTA). The gamma value is < 1, which demonstrates that the gel dose measurement agrees with TPS dose calculation within the 3%/3 mm criterion. Our results showed the pass rates of over 91% for the 90% isodose volume, 96% for the 80% isodose volume, and 95% for critical organ areas, which are acceptable for clinical deliveries (i.e., usually above 90%).
Conclusion
This study used MAGAT polymer gel with cone-beam CT as a real-time dose reading tool for 3D dose measurement for RapidArc TM 
